Latest News

Royal Financial, Inc.  Announces Audited Fiscal Year 2019 Fourth Quarter and Year End Earnings Results

CHICAGO, Sept. 05, 2019 (GLOBE NEWSWIRE) — Royal Financial, Inc. (the “Company”) (OTCQX: RYFL), incorporated under the laws of Delaware on December 15, 2004, for the purpose of serving as the holding company of Royal Savings Bank (the “Bank”), announces the audited earnings results and statement of condition for the fiscal year ended 2019. Net income for the fourth quarter […]

AXON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Axon Enterprise, Inc. To Contact The Firm

AXON INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Axon Enterprise, Inc. To Contact The Firm

NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Axon Enterprise, Inc. (“Axon” or the “Company”) (NASDAQ: AAXN). If you invested in Axon stock or options and would like to discuss your legal rights, click here: .  There is no cost or obligation to you. You […]

SUNDIAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sundial Growers Inc. To Contact The Firm

SUNDIAL INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sundial Growers Inc. To Contact The Firm

NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sundial Growers Inc. (“Sundial” or the “Company”) (NASDAQ: SNDL). If you invested in Sundial stock or options and would like to discuss your legal rights, click here: .  There is no cost or obligation to you. You […]

Talend S.A. Announces Pricing of €125 Million Convertible Notes Offering

Talend S.A. Announces Pricing of €125 Million Convertible Notes Offering

REDWOOD CITY, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Talend S.A. (NASDAQ: TLND) today announced the pricing of €125 million aggregate principal amount of 1.75% convertible senior notes due 2024 (the “notes”), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”).  Talend also granted the initial purchasers […]

BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress

BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (), a leader in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, will present scientific data at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS, ), September 11-13th in Stockholm, Sweden. BrainStorm is conducting a Phase 2 […]